Inspire Medical's Earnings Surge in Q4
Inspire Medical Systems (NYSE:INSP), known for its innovative devices that use neurostimulation to treat sleep apnea, announced impressive fourth-quarter results on Feb. 10. Earnings per share (EPS) came in at $1.
Inspire Medical more than doubles bottom line on 25% sales growth in Q4
Inspire Medical Systems (NYSE:INSP) shares rose slightly after hours today on fourth-quarter results that beat the consensus forecast.
Inspire Medical Systems’s (NYSE:INSP) Q4: Beats On Revenue
Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 24.5% year on year to $239.7 million. The company expects the full year’s revenue to be around $947.
Inspire: Q4 Earnings Snapshot
Inspire expects full-year earnings to be $2.10 to $2.20 per share, with revenue in the range of $940 million to $955 million. This story was generated by Automated Insights ( http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSP at https://www.zacks.com/ap/INSP
Inspire Medical Systems targets $940M-$955M revenue in 2025 with Inspire V launch
Q4 2024 Management View CEO Tim Herbert highlighted milestones in 2024, including surpassing 90,000 patients treated with Inspire therapy, FDA approval of the Inspire V neurostimulator, and achieving full-body MRI compatibility in the European Union.
Inspire (INSP) Reports Q4 Earnings: What Key Metrics Have to Say
Inspire Medical Systems (INSP) reported $239.72 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 24.5%. EPS of $1.15 for the same period compares to $0.
Verywell Health on MSN3d
How Does an Implant for Sleep Apnea Work?
An implant for sleep apnea is one of the few CPAP alternatives. This article compares hypoglossal nerve stimulation and ...
Inspire Medical Receives Investigative Demand from Justice Department
Inspire Medical Systems said it is cooperating with U.S. Justice Department probe of allegations into allegations of false claims related to its Inspire system apnea implant. Shares fall 5.5% to $171 ...
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook
MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, ...
WebMD28d
Sleep Apnea: Latest Research
For treatment resistant cases a surgical device called Inspire (hypoglossal nerve surgery ... Researchers have been on the hunt for new ways to treat sleep apnea and prevent its complications.
Implant lets sleep apnoea patient breathe again
A woman who has suffered with sleep apnoea for a decade is finally able to breathe and sleep again thanks to a new implant.